Chikungunya Virus, Cameroon, 2006 by Peyrefitte, Christophe N. et al.
DISPATCHES
768  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 5, May 2007
Chikungunya Virus, 
Cameroon, 2006
Christophe N. Peyreﬁ  tte,* Dominique Rousset,† 
Boris A.M. Pastorino,* Regis Pouillot,† 
Maël Bessaud,* Fabienne Tock,* 
Helene Mansaray,‡ Olivier L. Merle,* 
Aurelie M. Pascual,* Christophe Paupy,§ 
Aurelia Vessiere,† Patrice Imbert,¶ 
Patrice Tchendjou,† Jean-Paul Durand,* 
Hugues J. Tolou,* and Marc Grandadam*
We report the isolation of chikungunya virus from a pa-
tient during an outbreak of a denguelike syndrome in Cam-
eroon in 2006. The virus was phylogenetically grouped in 
the Democratic Republic of the Congo cluster, indicating a 
continuous circulation of a genetically similar chikungunya 
virus population during 6 years in Central Africa.
C
hikungunya virus (CHIKV), formerly only an anecdot-
ally described arbovirus, is now a worldwide public 
health problem (1). Recently, numerous cases of CHIKV 
infection have been reported from a major outbreak of 
febrile illness around the Indian Ocean, which included 
Comoros, Mauritius, Réunion Island (2,3),  and  southern       
India (4).
CHIKV is widely distributed in tropical Africa (5,6) 
and in Asia (7). In Africa, until 2000, the virus was de-
scribed as endemic, perpetuated through a sylvatic cycle 
involving wild primates, humans, and mosquitoes of the 
genus Aedes (2,8). During the past 6 years, the urban cycle 
has also tended to play a role in Central Africa (6). Never-
theless, although recent serologic surveys suggest a high 
prevalence of Togaviridae, Flaviviridae, and Bunyaviridae 
(9,10), understanding of the circulation and effects of arbo-
viruses in Cameroon remains imprecise. This lack of un-
derstanding may reﬂ  ect confusion between arboviral infec-
tions and hyperendemic Plasmodium falciparum infection.
We report the ﬁ   rst isolation, to our knowledge, of 
CHIKV in Cameroon. The virus was identiﬁ  ed during an 
outbreak of a febrile syndrome in French soldiers in Douala 
and in patients from an urban medical center in Yaoundé. 
We also found evidence of cocirculation of CHIKV and 
dengue virus (DENV).
The Study
In Douala, Cameroon, 2 sporadic cases of a dengue-
like syndrome were recorded in French soldiers (patients 1 
and 2) on April 3 and May 22, 2006, respectively (Table). 
From the end of May through the end of July 2006, more 
cases of denguelike syndrome, which included fever, asthe-
nia, maculopapular rashes, and arthralgia, were observed 
in Yaoundé. The number of patients who sought treatment 
at the Yaoundé Medical Center peaked in mid-June 2006. 
Blood samples were collected from 30 of the 40 patients 
who visited the medical center. The 30 patients’ ages 
ranged from 1 to 54 years. The delay between the onset 
of symptoms and the sampling ranged from 0 to 39 days 
with a median of 4 days (Table). All but 1 patient lived in 
Yaoundé, and none of these patients had a history of travel 
abroad or from Yaoundé. Nine patients were Cameroonian, 
and all other patients were from other countries; 15 patients 
were female. A blood sample from a 53-year-old woman 
who returned to France from Yaoundé was also received. 
All patients had negative results for P. falciparum accord-
ing to rapid test (Core Malaria Pf, Core Diagnostics, Bir-
mingham, UK) and thick smear examination.
Serum specimens were tested for immunoglobulin M 
(IgM) and IgG antibodies speciﬁ  c for DENV, West Nile 
virus (WNV), Wesselsbron virus, Rift Valley fever virus, 
Bunyamwera virus, and CHIKV by IgM-antibody capture 
(MAC-ELISA) and IgG sandwich ELISA, respectively 
(11). A serum sample was consider positive if the optical 
density (OD) ratio of viral antigen to uninfected cells was 
>3. The presence of CHIKV, DENV, and WNV genomes 
was tested for by speciﬁ  c real-time reverse transcription 
PCR (RT-PCR) (12). Virus isolation on C6/36 and Vero 
cells was attempted on samples that were positive by RT-
PCR (11).
The serologic follow-up of patient 1 (Table) for a 3-
week period detected seroconversion to a virus antigeni-
cally related to CHIKV virus (the OD ratios obtained with 
the second sample were >3) for IgM and IgG. A sample 
from patient 2 was obtained the day after the onset of 
symptoms, and no antibodies to all tested arboviruses were 
detected. However, the specimen was positive by real-time 
RT-PCR for CHIKV. The patient’s sample yielded CHIKV 
when cultured, and the envelope gene was partially se-
quenced (position 10,238–11,367, GenBank accession no. 
EF051584). The 1.2-kb sequence genetic analysis did not 
show any codon deletion or insertion when compared with 
other African CHIKV sequences available in the GenBank 
database (3,6,8). A high degree of identity was observed 
when the sequence was compared with the Democratic 
Republic of the Congo (DRC) strains isolated in 2000 (6). 
Paired identity ranged from 97% to 98.1% at the nucleotide 
level and from 98.7% to 99.3% at the amino acid level. 
The Cameroon isolate displayed a higher nucleotide diver-
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gence (paired identity ranging from 95% to 95.5%) when 
compared with the 2006 Réunion Island strains (2,3,13). 
However, amino acid sequences were highly conserved 
(99%–99.5%). The sequence identity among these isolates 
highlights their common origin and particularly the genetic 
stability of CHIKV despite the 6 years and the geographic 
distance from the DRC outbreaks. As shown in the phylo-
genetic tree (Figure), the CHIKV Cameroon strain clustered 
with DRC CHIKV strains with a high bootstrap value of 
100. This genotype of CHIKV was closely related to strains 
from the Central African Republic and the 1982 Uganda 
isolate (6,8). The close genetic relationship suggests a con-
tinuous circulation of a homologous CHIKV population in 
Central Africa with a high degree of genetic stability. The 
genetic stability of the Central African CHIKV strains dur-
ing 24 years, whether associated with epidemic or sporadic 
cases, highlights the peculiar importance of the few muta-
tions detected in the recent Réunion Island isolates (3). This 
also suggests that the Central African strain CHIKV zone 
of circulation now includes India (4), the Indian Ocean, and 
Cameroon.
The phylogenetic tree also illustrates the differences 
between the Cameroon isolates and the Asian subgroup 
isolates. Moreover, when compared with Asian CHIKV, 
including the 2006 isolates, the Cameroon strain showed 
91%–91.9% and 96.8%–98.8% identity at the nucleotide 
and amino acid levels, respectively. Despite the similar-
ity, cross-neutralization experiments must be conducted to 
conﬁ  rm the protective effect of the Asian CHIKV-based 
vaccine against Central African strains (2).
Among patients from Yaoundé, 1 (patient 11) had only 
IgM antibodies speciﬁ  c to CHIKV, while patients 18 and 
Table. Characteristics of patients with febrile acute denguelike syndrome, Cameroon, 2006* 
Patient no. Sex/age, y City
Symptom 
onset
Sampling
date Delay, d IgM† IgG† PCR‡
1 M/35 Douala 3 Apr 7 Apr 4 Neg Neg Neg
1 M/35 Douala 3 Apr 11 May 21 Pos CHIKV Pos CHIKV Neg
2§ M/36 Douala 22 May 23 May 1 Neg Neg Pos CHIKV
3 F/54 Yaoundé 11 Jun 12 Jun 1 Neg Neg Neg
4 F/49 Yaoundé 10 Jun 13 Jun 3 Neg Neg Neg
5 F/42 Yaoundé 11 Jun 12 Jun 1 Neg Neg Neg
6 F/41 Yaoundé 7 Jun 7 Jun 0 Neg Pos Flavi Neg
7 M/38 Yaoundé 15 Jun 19 Jun 4 Neg Neg Neg
8 M/30 Yaoundé 18 Aug 19 Jun 1 Neg Neg Neg
9 M/21 Yaoundé 15 Jun 19 Jun 4 Neg Neg Neg
10 F/32 Yaoundé 21 Jun 22 Jun 1 Neg Neg Neg
11 F/22 Yaoundé 19 Jun 26 Jun 7 Pos CHIKV Neg Neg
12 F/53 Imported 20 Jun 26 Jun 6 Pos CHIKV Pos CHIKV Neg
13 M/42 Yaoundé 24 Jun 27 Jun 3 Neg Pos Flavi Neg
14 F/42 Yaoundé 18 Jun 28 Jun 10 Neg Neg Neg
15 F/27 Yaoundé 18 Jun 29 Jun 11 Neg Pos Flavi Neg
16 F/43 Yaoundé 26 Jun 30 Jun 4 Neg Neg Neg
17 M/31 Yaoundé 16 Jun 30 Jun 14 Neg Neg Neg
18 F/37 Yaoundé 22 May 30 Jun 39 Pos CHIKV Pos CHIKV Neg
19 F/45 Yaoundé 10 Jun 30 Jun 20 Neg Neg Neg
20 M/45 Yaoundé 22 Jun 30 Jun 8 Neg Pos Flavi
and CHIKV
Neg
21 M/1 Yaoundé 23 Jun 30 Jun 7 Neg Neg Neg
22 F/9 Yaoundé 10 Jun 30 Jun 20 Neg Neg Neg
23 M/4 Yaoundé 26 Jun 30 Jun 4 Neg Neg Neg
24 M/54 Yaoundé 4 Jul 6 Jul 2 Neg Neg Neg
25 F/45 Yaoundé 14 Jun 5 Jul 21 Neg Neg Neg
26 M/48 Yaoundé 24 Jun 6 Jul 12 Neg Neg Neg
27 M/20 Yaoundé 30 Jun 1 Jul 1 Neg Neg Neg
28 M/37 Yaoundé 4 Jul 11 Jul 7 Pos CHIKV Pos CHIKV Neg
29 M/36 Yaoundé 9 Jul 11 Jul 2 Neg Neg Neg
30 M/33 Yaoundé 28 Jun 10 Jul 12 Neg Neg Neg
31 M/32 Yaoundé 10 Jul 12 Jul 2 Neg Neg Pos DENV
32 F/38 Yaoundé 16 Jul 17 Jul 1 Neg Neg Neg
33 M/45 Yaoundé 21 Jul 26 Jul 5 Neg Neg Neg
*IgM, immunoglobulin M; Neg, negative; Pos, positive; CHIKV, chikungunya virus; Flavi, flavivirus; DENV, dengue virus. 
†DENV, West Nile virus, Wesselsbron virus, Rift Valley fever virus, Bunyamwera virus, and CHIKV antibodies tested. 
‡DENV, West Nile virus, CHIKV tested by real-time reverse transcription–PCR.  
§CHIKV isolation successful. DISPATCHES
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28 had both IgM and IgG antibodies speciﬁ  c to CHIKV 
(Table). One patient from Cameroon (patient 20) had IgG 
speciﬁ  c to both CHIKV and ﬂ  avivirus. Three patients (nos. 
6, 13, and 15), 2 of whom were Cameroonian, had antibod-
ies speciﬁ  c for ﬂ  avivirus. All samples were negative for 
WNV and CHIKV by RT-PCR. One sample (from patient 
31) was positive for DENV; however, no virus was detect-
ed by cell culture. These results suggested a cocirculation 
of CHIKV and dengue virus during the same period, which 
is consistent with the suspected circulation of dengue virus, 
CHIKV, and yellow fever virus observed in a study from 
2000 through 2003 in Cameroon (9).
In Cameroon, as in DRC (6), patients were likely in-
fected in urban or periurban centers (Yaoundé, the capital 
of Cameroon; Douala, a major city). These infections oc-
curred in a context where Aedes albopictus tends to replace 
indigenous Ae. aegypti in rural and urban Cameroonian en-
vironments (14). This ﬁ  nding suggests that urban cycles and 
urban vectors, in addition to the traditional forest-dwelling 
vectors, may play an important role in the maintenance and 
ampliﬁ  cation of CHIKV in Africa. 
Conclusions
Since its ﬁ  rst isolation in 1953 (8), CHIKV has been 
isolated in different Central African countries (8,6). Until 
now, only 2 alphavirus strains antigenically suspected to be 
CHIKV had been isolated from human patients in Camer-
oon (15). Recent serosurvey studies suggested a possible 
CHIKV circulation in Cameroon (9,10). Our Cameroon 
CHIKV isolate conﬁ  rmed its circulation in this country. 
Our study suggests a 6-year continuous circulation of ge-
netically stable and indigenous strains in Central Africa 
rather than importation of CHIKV from the recent Indian 
Ocean or Asian outbreaks. Moreover, the genetic stability 
of the Central African CHIKV highlights the importance of 
the unique molecular features that was shown in Réunion 
Island isolates (3).
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